Skip to content

RehaSleep Register - Prevalence of Sleep Apnea in Cardiac Rehabilitation

RehaSleep Register - Prevalence of Sleep Apnea in Cardiac Rehabilitation

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01830036
Acronym
RehaSleep
Enrollment
1300
Registered
2013-04-11
Start date
2011-06-30
Completion date
2017-04-30
Last updated
2015-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep Apnea

Keywords

cardiological treatment, sleep Apnea

Brief summary

Prevalence of sleep-related breath disturbance in patients in cardiac rehabilitation. The aim of the register is to enable a better diagnosis and early treatment initiation in the context of secondary prevention. In addition to the prevalence, the further course of the patients shall be documented after hospital discharge to verify any gaps (sleep laboratory, therapy introduction) and emphasize the importance of rehabilitation and to examine the possibility of initiating therapy in rehabilitation.

Interventions

None listed

Sponsors

ResMed
CollaboratorINDUSTRY
RWTH Aachen University
Lead SponsorOTHER

Study design

Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* terminal cardiac treatment in cardiac rehabilitation facility * for example: Myocardial infarction, bypass surgery, stent implantation, valve replacement, ICD, CRT, pacemakers, heart failure

Exclusion criteria

* no informed consent form signed * limited consent capacity (Dementia, addiction, psychosis) * pregnancy

Design outcomes

Primary

MeasureTime frameDescription
cardiological treatmentApril 2013all Patients who are admitted under a terminal cardiac treatment (myocardial infarction, bypass surgery, stent implantation, valve replacement, ICD, CRT) in a cardiac rehabilitation faciliy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026